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Alan D. W. Dobsonc and Marcel Jasparsd
With the adoption of the Nagoya Protocol in 2010, an additional legal instrument under the Convention on
Biological Diversity (1992), the legal landscape surrounding the access to and utilization of genetic
resources will change. This is likely to impact working procedures for scientists, turning pre-existing
ethics into legal obligations. The aim of this article is to inform scientists on the global access and
beneﬁt-sharing framework which has been set by the Convention on Biological Diversity and its Nagoya
Protocol, focusing speciﬁcally on their application to marine genetic resources for which the United
Nations Convention on the Law of the Sea (1982) also has relevance.1 Introduction
Marine biodiscovery depends upon access to marine organisms,
collectively termed marine genetic resources (MGR). Scientists,
familiar with the potential challenges of collectingMGR samples
in the marine environment, are oen less aware of the legal and
policy frameworks governing access to MGR. The Convention on
Biological Diversity (CBD)1 and its Nagoya Protocol on Access to
Genetic Resources and the Fair and Equitable Sharing of Bene-
ts Arising from their Utilization (Nagoya Protocol),2 as well as
the United Nations Convention on the Law of the Sea (UNCLOS)3
are of particular relevance in this regard.
This article will consider the CBD and its Nagoya Protocol, as
well as the UNCLOS and examine how these legal frameworks
impact marine scientic research, depending on the areas in
which the MGR are collected and on the purpose of the
research. Further it will provide a clear overview of the mecha-
nisms in place and the steps which need to be taken in order to
comply with these rules.1.1 The Convention on Biological Diversity and the Nagoya
Protocol
The CBD, which entered into force in 1993, addresses biodi-
versity irrespective of whether it is terrestrial or aquatic in1, 8400 Ostend, Belgium. E-mail: info@
sberger Allee 108-112, D-53175 Bonn,
ty College Cork, Cork, Ireland. E-mail: a.
hemistry, University of Aberdeen, Old
SI) available: Authors’ biographies. Seeorigin. It has three main objectives: the conservation of biodi-
versity, the sustainable use of its components and, while
declaring the sovereignty of states over their natural resources
(article 3), it encourages the creation of access and benet-
sharing (ABS) mechanisms when it comes to the exploitation or
utilization of genetic resources (art. 1 & 15). This last objective
was devised to share the costs as well as the benets of biodi-
versity conservation between developed and developing coun-
tries. Whilst ABS discussions are oen limited to questions
around the sharing of monetary benets from research and
development, it should be recognized that biodiscovery rarely
results in lucrative patents and products. Thus, non-monetary
benets must also be considered. Furthermore, the objective of
ABS is broader than promoting the sharing of the benets
gained from the use of genetic material. ABS is also about
facilitating access to genetic resources (ref. 14 p. 28).
This is partly why the Conference of the Parties to the CBD
adopted the Nagoya Protocol in 2010, which is an additional
agreement to the Convention that is expected to enter into force
in 2014. It further elaborates the CBD's ABS mechanism and
promotes the development of worldwide ABS frameworks which
will enable stakeholders to better understand and comply with
national ABS procedures. In addition, the Protocol claries
some aspects of the CBD, expressly including biochemical
compounds within the scope of the framework and providing
examples of both monetary and non-monetary benets in its
annex.1.2 The United Nations Convention on the Law of the Sea
Because it has evolved through centuries of traditions and
customary rules implicitly accepted and more or less eﬀectively
implemented by the various maritime actors, the law of the sea
is a strongly rooted and particular eld of law. The UNCLOS was
adopted in 1982 (entered into force in 1994), and can beThis journal is © The Royal Society of Chemistry 2014
Fig. 1 ABS Framework in the Nagoya Protocol. Source: Factsheet on
Access and Beneﬁt-Sharing, Secretariat of the Convention on Bio-
logical Diversity, 2011.15
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View Article Onlinedescribed as a codication of these customary rules, with some
novel additions. In its simplest terms, the UNCLOS is a global
and general framework setting the boundaries of states' juris-
diction and regulating the activities taking place there,
including marine scientic research (MSR). Although it does
not refer explicitly to genetic resources, it does address ‘living’,
‘natural’ or ‘biological’ resources in terms of conservation,
exploitation and research (ref. 4 p. 150). Therefore a state that
regulates MSR in its waters may impose certain access restric-
tions to the MGR within its jurisdiction.
It is important that scientists are aware of the distinct
regimes governing access to MGR under both the CBD and its
Nagoya Protocol on the one hand, and under the UNCLOS on
the other hand. Compliance with the provisions a state may
have in place under the UNCLOS does not ensure compliance
with national ABS regime under the CBD and its Nagoya
Protocol, and vice versa.
2 Global common mechanism of
ABS: a harmonized international
framework
As mentioned previously, when the Nagoya Protocol enters into
force all state parties will be expected to have a national regime
which meets global standards, thereby enabling users to know
what to expect whenever they wish to access and utilize MGR.
The Protocol's mechanism (Fig. 1) will impact bioprospecting
activities independently of the way samples are initially
acquired. When the genetic material is accessed from an ‘ex
situ’ collection, i.e. a biorepository, then the access provisions of
the CBD and the Nagoya Protocol apply. If, however, the genetic
material is accessed ‘in situ’ via a sampling expedition then the
UNCLOS provisions regarding MSR will also apply. Prior to
considering the maritime specicities, it is rst important to
understand the ABSmechanism. As the Nagoya Protocol further
elaborates the CBD's ABS provisions, the following explanations
will mainly focus on the Protocol and not on the Convention.
2.1 Prior informed consent and mutually agreed terms
The ABS regime of the Nagoya Protocol is based on the nego-
tiation of mutually agreed terms (MAT) in order to be granted
access by the prior informed consent (PIC) of the providing state
(art. 5 & 6). Indeed, the applicant for PIC – the future user –must
rst comply with the domestic ABS requirements by negotiating
MAT, which includes issues such as access conditions, material
transfer rights and benet-sharing agreements with the
provider (Fig. 1). Oen the rst point of contact in a providing
country is a partner institution to the user or to the research
project. Both the CBD and the Protocol encourage the partici-
pation of nationals from the provider country on a foreign
research project. The content of MAT has to be guided by
domestic measures, which may require some specic aspects.
The most probable and common requirements that can be
expected are provided as examples by the Protocol (art. 6) and
include: terms on benet-sharing, terms on third party use, and
terms on the change of intent.This journal is © The Royal Society of Chemistry 20142.1.1 Subsequent third-party transfer. Subsequent third-
party transfer is a key challenge of the negotiation process, that
is the future transfer of the collected material and/or associated
knowledge to a third party interested in the utilization of such
material/knowledge, but not involved in the original negotia-
tion of MAT. Given the nature of the biodiscovery pipeline,
which may include multiple stakeholders,5 it is crucial to set
clear terms on subsequent transfers from the onset. In this
respect, the coastal state can either choose not to legislate,
leaving the negotiations free, or it can regulate it, e.g. by
imposing a comeback clause that would oblige the user to seek
the consent of the source country authorities for each new
transfer. Monitoring the utilization of the genetic resources is
indeed important for ABS implementation.
2.1.2 Benet-sharing. The benet-sharing aspects of MAT
are central to the negotiating process. As mentioned before,
benet-sharing does not only imply monetary benets (such
as payments of royalties), and indeed in most cases the main
benets will be non-monetary. Annex I of the Protocol
provides examples of various types of benets, and it is
emphasized that benets should as much as possible be
directed towards the conservation and sustainable use of
biodiversity (art. 9). The sharing of results, participation of
nationals in product development, contributions to education
and training in the providing country, technology and
capacity transfer are some of the most common benets
currently found in MAT. Partnerships and contracts have long
been customary practice in this respect, and can generally
be considered as best practice for future benet-sharing
agreements.6,7Nat. Prod. Rep., 2014, 31, 612–616 | 613
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View Article Online2.1.3 Change of intent. The biodiscovery process is a
continuum which oen begins with accessing MGR for basic
research purposes but may evolve into a commercially driven
process via an applied research phase. Delineating each of these
phases can be diﬃcult, however, identifying the change of intent
is also an important aspect of MAT and must be considered. In
this regard, a two phase approach may be recommended, as
applicable: rstly negotiating MAT as a ‘basic research agree-
ment’ with the possibility to secondly renegotiate a ‘commercial
development agreement’ when there is a change of intent due to
a new commercial interest arising from the research, and not
only because a patent was obtained on a product.6 Indeed,
because certain patents do not necessarily entail commercial
consequences, the granting of such patents may not have any
eﬀect on the original bioprospecting permit if the original MAT
were negotiated to provide for such a situation.Fig. 2 Maritime Boundaries in the UNCLOS. Source: Arctic Council,
Arctic Marine Shipping Assessment 2009 Report (Tromsø, Norway:
2009), p. 52, available at: www.pame.is/images/stories/PDF_Files/
AMSA_2009_Report_2nd_print.pdf.2.2 Compliance requirements
The negotiation of clear and legally certain MAT strongly
inuence the decisions of competent national authorities on
whether to grant PIC to accessing MGR. The competent
authority is the administration appointed by the state to oﬃ-
cially approve the partnership's MAT. The PIC shall be granted
in a written form that will eventually acquire the legal value of
an internationally recognized permit (art. 17). This permit (or its
equivalent) is the key document of the ABS mechanism, as it is
meant to ensure legal certainty for both the user and the
provider. It aﬀords security to the provider, and enables the user
to prove it has acquired the material legally and can thus
progress safely and lawfully further along the biodiscovery
pipeline.
This is of particular relevance for the user since the Nagoya
Protocol requires that the parties provide for measures ensuring
that genetic resources being utilized within their jurisdiction
were acquired in compliance with the provider's ABS legislation
(art. 15). Therefore benet-sharing agreements are not simply
an ethical practice, but are a legal obligation with all the rele-
vant consequences in case of non-compliance. Potential
consequences are: suspension or even cessation of the bio-
discovery process, nes, inability to apply for a patent or to
commercialize, etc. It is noteworthy that the European Union is
currently elaborating a regulation to ensure that all users of
genetic resources have complied with the domestic laws of
providing countries, before conducting any research and
development within the Union.
2.2.1 Competent national authorities (CNA). One of the
consequences of the above described bilateral ABS approach is
the involvement of state's competent authorities in the appli-
cation process. The CNA might for instance be a department of
the source country's Ministry of Environment that is respon-
sible for granting PIC. This is in fact the case in Costa Rica,
where the National Commission of Biodiversity Management
grants the bioprospecting permits (www.conagebio.go.cr/).
However, it might also be the case that multiple permits need to
be obtained from diﬀerent government institutions in order to
get proper PIC, as is for example the case in Kenya.8 It all614 | Nat. Prod. Rep., 2014, 31, 612–616depends on the provider country's legal and institutional set-up.
Considering MGR the situation with regard to the CNA may
again diﬀer. For example, in South Africa, the CNA for terrestrial
bioprospecting is the Department of Environmental Aﬀairs, but
for MGR the Oceans and Coasts branch is competent,9 while in
Norway it is the Ministry of Fisheries.10
Returning to the potential overlap between the UNCLOS and
the CBD frameworks, where a state has implemented measures
with respect to both, it is important to note that distinct
national authorities might be competent for diﬀerent aspects of
the same activity. The onus is on the researchers to ensure that
they have contacted all relevant authorities and established the
procedures which they may be required to follow in order to
access MGR.
3 The UNCLOS and the Nagoya
Protocol: overlapping frameworks for
the collection of samples on site
The provisions of the CBD and its Nagoya Protocol apply to
biodiversity accessed within the national jurisdiction of coastal
states. Since the UNCLOS grants jurisdiction to coastal states up
to 350 nautical miles (nm) from the baselines, the Nagoya
Protocol (which has to be implemented in respect of the
UNCLOS according to art. 4) also applies in these maritime
areas. And because both legal frameworks set their own rules to
regulate either ‘MSR’ (UNCLOS part XIII) or ‘Utilization of
genetic resources’ (NP art. 1), the situation is likely to result in
the application of two distinct procedures for the same activity.
3.1 Marine scientic research under the UNCLOS
The UNCLOS grants various rights to the coastal states
depending on the specic maritime areas (Fig. 2 for delim-
itations). The territorial sea can be compared to the prolonga-
tion of the state's territory: meaning the state has full
sovereignty over these waters with all the discretion that it
implies, including the regulation of MSR (art. 2). But the juris-
diction of coastal states over their natural resources extends far
beyond the 12 nm of the territorial sea. Indeed, within the
200 nm of the exclusive economic zone (EEZ) as well as on theThis journal is © The Royal Society of Chemistry 2014
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View Article Onlinecontinental shelf (CS) which can be up to 350 nm, the coastal
state is granted exclusive rights, which must be diﬀerentiated
from sovereignty in the sense that such rights only apply to
specic activities (i.e. protection of the environment, or the
exploration and exploitation of natural resources).
One of the rights granted to the coastal state relates directly
to MSR. Indeed, the coastal state has to be notied six months
in advance of any MSR project requiring access to its EEZ or CS.
It also has the right to require the participation of national
observers in the project (art. 248). Because this procedure is
more related to the supervision of the traﬃc and ongoing
activities within national jurisdiction than to the regulation of
access to resources for any applied purpose and exploitation,
the competent authority responsible for granting the authori-
zation is oen the navy. For instance, in Chile the Oﬃce of the
Commander-in-Chief of the Navy grants the authorization
following consultation with the Navy Hydrographic and
Oceanographic Service.11 Consent from the coastal state is easily
acquired since one of the UNCLOS objectives is to promote
MSR, and the state's consent should always be granted ‘under
normal circumstances’ (art. 246).4 Even though it is beyond the
scope of this article to discuss what can be considered as
abnormal circumstances, it is noteworthy that the discretionary
power of the coastal state to refuse the access of a cruise
campaign to its waters in cases where there might be a ‘signif-
icant eﬀect’ on the exploitation of natural resources (art. 246).3.2 In situ marine genetic resources under the Nagoya
Protocol
Since states have sovereignty over the natural resources found
within their jurisdiction under the CBD, it is very important to
refer to the Convention and its Nagoya Protocol together with
the UNCLOS to understand where this jurisdiction extends.
Within the 200 nm limits of the EEZ and CS it is clearly stated
that the coastal state has jurisdiction over all ‘natural
resources’ (art. 56 & 77). However it is worth mentioning that
the jurisdiction of states can sometimes extend up to 350 nm
(art. 77), aer the extension of the CS was submitted to the
Commission on the Limits of the CS (Annex II). At present, only
18 states have acquired such extended rights (www.un.org/
depts/los/clcs_new/clcs_home.htm). These rights grant states
jurisdiction over the ‘sedentary species’ (benthos) of the seabed
therein. However, for the water column above the extended CS
the freedom of the High Seas applies. Therefore, if benthic
organisms are sampled from the seabed within such extended
jurisdiction, the appropriate consent of the coastal state must
be sought.
Consequently, what should be borne in mind is that PIC and
MAT are required for any activity related to MGR up to 200 nm
(water column) or 350 nm (extended CS), and that the sole
authorization of conducting research will not be suﬃcient. Two
permits, probably granted by diﬀerent authorities, may there-
fore be required: an authorization to conduct marine research
within the coastal state's jurisdiction and a permit to access and
utilize MGR. However, it is not clear when MSR becomes bio-
prospecting, and when or, to what extent, the commercial intentThis journal is © The Royal Society of Chemistry 2014becomes decisive for the denition of the activity. To further
complicate matters national legislations implementing the
Protocol could well provide diﬀerent answers to this question
from one country to another, as several ‘denitions’ of bio-
prospecting exist globally. It is thus probably safest to system-
atically enter into a relationship with a partner from the source
country and include a change of intent clause, i.e. to foresee any
subsequent and unplanned future commercial exploitation.Concluding remarks
Although the Nagoya Protocol is a new legally binding instru-
ment which will certainly add administrative layers to the
conduct of MSR and related bioprospecting activities, it will also
bring more legal certainty to the biodiscovery pipeline and,
through the negotiation of agreements, avoid the misappro-
priation and misuse of genetic resources.12 In this regard, all
parties involved in the value chain of the utilization of legally
acquired genetic resources should benet from the security
thus provided and pursue their work safely. To further
encourage good practice, we would recommend that relevant
scientic journals may wish to adopt a policy whereby accep-
tance of a research paper which relates to the access or utili-
zation of a genetic resource would be contingent on a statement
ensuring compliance with existing regulations.
It is worth mentioning that, while waiting for the entry into
force of the Protocol and the ratication of the parties, some
uncertainties remain. These are, amongst others, the reparti-
tion of MGR in areas involving several providing states or in
situations where the same MGR can be found within and
beyond national jurisdictions. It is also noteworthy to empha-
size the regime of the international high seas and deep seabed
areas. Although states are obliged to disseminate information
and knowledge from MSR in these areas – which could be
compared to a form of non-monetary benets similar to those
under the CBD and its Nagoya Protocol – the access to genetic
resources beyond national jurisdiction remains free at the
moment. This is likely to change in the next decade as current
discussions within the United Nations General Assembly appear
to be heading towards the possible elaboration of an additional
agreement to the UNCLOS with respect to ABS of MGR in
international waters.4,13AbbreviationsABS Access and Benet-Sharing
Art. Article (of a Convention)
CBD Convention on Biological Diversity
CNA Competent National Authority
CS Continental Shelf
EEZ Exclusive Economic Zone
MAT Mutually Agreed Terms
MGR Marine Genetic Resources
MSR Marine Scientic Research
PIC Prior Informed Consent
UNCLOS United Convention on the Law of the SeaNat. Prod. Rep., 2014, 31, 612–616 | 615
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